Literature DB >> 26790673

Resveratrol fails to affect cocaine conditioned place preference behavior, but alleviates anxiety-like behaviors in cocaine withdrawn rats.

Panpan Hu1, Wei Zhu1, Chao Zhu2, Lai Jin2, Yun Guan3, Xiaowei Guan4.   

Abstract

RATIONALE: Resveratrol participates in regulating abnormal behaviors in psychostimulant-exposed animals.
OBJECTIVES: To examine effects of resveratrol on relapse and anxiety-like behaviors in cocaine withdrawn rats and to investigate possible molecular mechanisms underlying resveratrol effects in hippocampus (HP) and prefrontal cortex (PFC).
METHODS: Conditioned place preference (CPP) assay and elevated plus maze (EPM) test were used to examine cocaine CPP behavior and anxiety-like behaviors in rats, respectively. Resveratrol was administrated to cocaine withdrawn rats. Levels of MDA, GSH and SOD were examined to evaluate oxidative status, and levels of IL-6, IL-1β and TNF α were measured to examine inflammatory status and levels of caspase-3 and BAX was examined to evaluate apoptotic status in HP and PFC. SIRT expression was also examined here.
RESULTS: Resveratrol did not affect cocaine CPP behaviors, but attenuated anxiety-like behaviors in cocaine withdrawn rats. Levels of MDA and TNFα in PFC, and levels of MDA, SOD, GSH, IL-6, IL-1β, TNFα, caspase-3 and BAX in HP, but not SIRT1 expression in both regions were significantly changed during cocaine withdrawal period. Except SOD, resveratrol reversed above neurochemical changes induced by cocaine withdrawal. Furthermore, RSV induced a greater upregulation of SIRT1 expression in PFC in cocaine withdrawn rats than that in saline controls.
CONCLUSIONS: Current findings suggest that resveratrol may influence behaviors in cocaine withdrawn rats. Oxidative stress, inflammation, apoptosis, and SIRT1 signaling pathway in HP or PFC might be involved in mediating effects of RSV on behaviors in cocaine withdrawn rats.

Entities:  

Keywords:  Anxiety; Cocaine; Conditioned place preference; Resveratrol; SIRT1; Withdrawal

Mesh:

Substances:

Year:  2016        PMID: 26790673     DOI: 10.1007/s00213-016-4210-4

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  38 in total

Review 1.  Structure and evolution of human sirtuins.

Authors:  Domenico Bordo
Journal:  Curr Drug Targets       Date:  2013-06-01       Impact factor: 3.465

2.  Early abstinence of crack-cocaine is effective to attenuate oxidative stress and to improve antioxidant defences.

Authors:  Aline Zaparte; Thiago W Viola; Rodrigo Grassi-Oliveira; Maurilio da Silva Morrone; José C Moreira; Moisés E Bauer
Journal:  Psychopharmacology (Berl)       Date:  2014-10-23       Impact factor: 4.530

Review 3.  Cocaine addiction: psychology and neurophysiology.

Authors:  F H Gawin
Journal:  Science       Date:  1991-03-29       Impact factor: 47.728

Review 4.  Biological effects of resveratrol.

Authors:  J W Kosmeder; J M Pezzuto
Journal:  Antioxid Redox Signal       Date:  2001-12       Impact factor: 8.401

Review 5.  Resveratrol as a therapeutic agent for neurodegenerative diseases.

Authors:  Albert Y Sun; Qun Wang; Agnes Simonyi; Grace Y Sun
Journal:  Mol Neurobiol       Date:  2010-03-21       Impact factor: 5.590

6.  Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations.

Authors:  F H Gawin; H D Kleber
Journal:  Arch Gen Psychiatry       Date:  1986-02

7.  Resveratrol attenuates oxidative damage and ameliorates cognitive impairment in the brain of senescence-accelerated mice.

Authors:  Gui-Shan Liu; Ze-Sheng Zhang; Bo Yang; Wei He
Journal:  Life Sci       Date:  2012-09-12       Impact factor: 5.037

8.  Essential role of SIRT1 signaling in the nucleus accumbens in cocaine and morphine action.

Authors:  Deveroux Ferguson; Ja Wook Koo; Jian Feng; Elizabeth Heller; Jacqui Rabkin; Mitra Heshmati; William Renthal; Rachael Neve; Xiaochuan Liu; Ningyi Shao; Vittorio Sartorelli; Li Shen; Eric J Nestler
Journal:  J Neurosci       Date:  2013-10-09       Impact factor: 6.167

9.  Anxiety Sensitivity, Emotional Avoidance, and PTSD Symptom Severity Among Crack/Cocaine Dependent Patients in Residential Treatment.

Authors:  James A Naifeh; Matthew T Tull; Kim L Gratz
Journal:  Cognit Ther Res       Date:  2012-06-01

10.  Oxidative stress biomarkers in some rat brain structures and peripheral organs underwent cocaine.

Authors:  Lucyna Pomierny-Chamioło; Andrzej Moniczewski; Karolina Wydra; Agata Suder; Małgorzata Filip
Journal:  Neurotox Res       Date:  2012-07-12       Impact factor: 3.911

View more
  5 in total

1.  Conditioned aversive responses produced by delayed, but not immediate, exposure to cocaine and morphine in male Sprague-Dawley rats.

Authors:  Kelsey G Guenther; Cassidy E Wideman; Erin M Rock; Cheryl L Limebeer; Linda A Parker
Journal:  Psychopharmacology (Berl)       Date:  2018-09-24       Impact factor: 4.530

2.  Normal glutathione levels in autopsied brain of chronic users of heroin and of cocaine.

Authors:  Junchao Tong; Paul S Fitzmaurice; Anna Moszczynska; Gausiha Rathitharan; Lee-Cyn Ang; Jeffrey H Meyer; Romina Mizrahi; Isabelle Boileau; Yoshiaki Furukawa; Tina McCluskey; Napapon Sailasuta; Stephen J Kish
Journal:  Drug Alcohol Depend       Date:  2018-06-23       Impact factor: 4.492

3.  Recent studies on resveratrol and its biological and pharmacological activity.

Authors:  Yong Joo Kim; Sun Ok Chung; Jae Kwang Kim; Sang Un Park
Journal:  EXCLI J       Date:  2017-04-27       Impact factor: 4.068

4.  Resveratrol modulates cocaine-induced inhibitory synaptic plasticity in VTA dopamine neurons by inhibiting phosphodiesterases (PDEs).

Authors:  Yan Li; Laikang Yu; Li Zhao; Fanxing Zeng; Qing-Song Liu
Journal:  Sci Rep       Date:  2017-11-15       Impact factor: 4.379

5.  Towards resolving the enigma of the dichotomy of resveratrol: cis- and trans-resveratrol have opposite effects on TyrRS-regulated PARP1 activation.

Authors:  Megha Jhanji; Chintada Nageswara Rao; Mathew Sajish
Journal:  Geroscience       Date:  2020-11-27       Impact factor: 7.713

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.